pharma news

News

Three more biotechs have revealed their intentions to list on Nasdaq - BlossomHill, Vogenx, and Latigo - as 2026 heads for a record IPO haul.

News

Venture financing for UK biotechs reached a five-year high in the second quarter of the year, with more than £2 billion raised, says BIA.

News

Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.

News

Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning the programme.

News

All 15-year-olds in the UK should be offered the meningitis B vaccine following the fatal outbreaks earlier this year, says the JCVI.

News

This week's round-up of private financings in the biotech arena features AdvanCell, alongside Draig, Drug Farm, MindRank AI, and Alchemab.